Reviva Historical Financial Ratios
| RVPH Stock | USD 2.61 0.16 5.78% |
Reviva Pharmaceuticals is promptly reporting on over 78 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 0.45, Invested Capital of 0.0, Average Payables of 3.5 M or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Reviva Pharmaceuticals financial condition quickly.
Reviva |
About Reviva Financial Ratios Analysis
Reviva PharmaceuticalsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Reviva Pharmaceuticals investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Reviva financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Reviva Pharmaceuticals history.
Reviva Pharmaceuticals Financial Ratios Chart
Add Fundamental
Dividend Yield
Dividend Yield is Reviva Pharmaceuticals Holdings dividend as a percentage of Reviva Pharmaceuticals stock price. Reviva Pharmaceuticals dividend yield is a measure of Reviva Pharmaceuticals stock productivity, which can be interpreted as interest rate earned on an Reviva Pharmaceuticals investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Return On Assets
A profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets.Most ratios from Reviva Pharmaceuticals' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Reviva Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. As of now, Reviva Pharmaceuticals' PB Ratio is increasing as compared to previous years. The Reviva Pharmaceuticals' current ROIC is estimated to increase to about 3.1 B, while Free Cash Flow Yield is projected to decrease to (0.24).
Reviva Pharmaceuticals fundamentals Correlations
Click cells to compare fundamentals
Reviva Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Reviva Pharmaceuticals fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Income Quality | 0.26 | 0.98 | 1.25 | 0.78 | 0.72 | 0.62 | |
| Return On Tangible Assets | (325.7) | (0.43) | (0.27) | (1.29) | (1.7M) | (1.6M) | |
| Effective Tax Rate | (9.46E-4) | (2.11E-4) | (7.05E-4) | (8.54E-4) | 431.89 | 453.48 | |
| Return On Capital Employed | 0.0553 | (0.33) | (0.35) | (1.89) | (6.1M) | (5.8M) |
Currently Active Assets on Macroaxis
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Return On Assets (2.34) | Return On Equity (17.95) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.